Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+3.38%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$97B
AUM Growth
-$517M
Cap. Flow
-$311M
Cap. Flow %
-0.32%
Top 10 Hldgs %
37.18%
Holding
506
New
13
Increased
130
Reduced
158
Closed
20

Sector Composition

1 Consumer Discretionary 29%
2 Healthcare 24.31%
3 Technology 17.32%
4 Communication Services 11.22%
5 Financials 6.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
COHR icon
351
Coherent
COHR
$15.2B
$17K ﹤0.01%
477
INMD icon
352
InMode
INMD
$947M
$17K ﹤0.01%
596
KFRC icon
353
Kforce
KFRC
$598M
$17K ﹤0.01%
295
SNA icon
354
Snap-on
SNA
$17.1B
$17K ﹤0.01%
86
AVY icon
355
Avery Dennison
AVY
$13.1B
$16K ﹤0.01%
100
CYTK icon
356
Cytokinetics
CYTK
$6.34B
$16K ﹤0.01%
340
ENTA icon
357
Enanta Pharmaceuticals
ENTA
$189M
$16K ﹤0.01%
318
EXPE icon
358
Expedia Group
EXPE
$26.6B
$16K ﹤0.01%
176
BRSL
359
Brightstar Lottery PLC
BRSL
$3.18B
$16K ﹤0.01%
1,024
JNJ icon
360
Johnson & Johnson
JNJ
$430B
$16K ﹤0.01%
99
LYFT icon
361
Lyft
LYFT
$6.91B
$16K ﹤0.01%
1,228
PRCT icon
362
Procept Biorobotics
PRCT
$2.26B
$16K ﹤0.01%
376
RMBS icon
363
Rambus
RMBS
$8.05B
$16K ﹤0.01%
630
GTM
364
ZoomInfo Technologies
GTM
$3.26B
$16K ﹤0.01%
+384
New +$16K
CHRS icon
365
Coherus Oncology, Inc. Common Stock
CHRS
$150M
$15K ﹤0.01%
1,585
+154
+11% +$1.46K
DG icon
366
Dollar General
DG
$24.1B
$15K ﹤0.01%
62
-7
-10% -$1.69K
GT icon
367
Goodyear
GT
$2.43B
$15K ﹤0.01%
1,525
+125
+9% +$1.23K
INSM icon
368
Insmed
INSM
$30.7B
$15K ﹤0.01%
707
KN icon
369
Knowles
KN
$1.85B
$15K ﹤0.01%
1,200
MRTX
370
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$15K ﹤0.01%
214
+18
+9% +$1.26K
BC icon
371
Brunswick
BC
$4.35B
$14K ﹤0.01%
219
+19
+10% +$1.22K
GKOS icon
372
Glaukos
GKOS
$5.39B
$14K ﹤0.01%
269
MAR icon
373
Marriott International Class A Common Stock
MAR
$71.9B
$14K ﹤0.01%
+100
New +$14K
TGT icon
374
Target
TGT
$42.3B
$14K ﹤0.01%
97
INFN
375
DELISTED
Infinera Corporation Common Stock
INFN
$14K ﹤0.01%
2,941